IDO1 and colitis: In addition, IDO1 inhibition resulted in increased mortality and disease severity in an experimental model of T cell mediated colitis, and transfusion of IDO overexpressing DCs was associated with long term allograft survival of recipients in a mouse model of small bowel transplantation (56, 69).